These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 27221265)

  • 1. Ganciclovir ophthalmic gel treatment shortens the recovery time and prevents complications in the adenoviral eye infection.
    Ozen S; Ozer MA
    Int Ophthalmol; 2017 Feb; 37(1):245-249. PubMed ID: 27221265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Ganciclovir 0.15% ophthalmic gel in the treatment of adenovirus keratoconjunctivitis].
    Yabiku ST; Yabiku MM; Bottós KM; Araújo AL; Freitas Dd; Belfort R
    Arq Bras Oftalmol; 2011; 74(6):417-21. PubMed ID: 22331114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of topical ophthalmic ganciclovir gel for the treatment of dogs with experimentally induced ocular canine herpesvirus-1 infection.
    Ledbetter EC; Nicklin AM; Spertus CB; Pennington MR; Van de Walle GR; Mohammed HO
    Am J Vet Res; 2018 Jul; 79(7):762-769. PubMed ID: 29943639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of topical application of 0.15% ganciclovir gel on cytomegalovirus corneal endotheliitis.
    Koizumi N; Miyazaki D; Inoue T; Ohtani F; Kandori-Inoue M; Inatomi T; Sotozono C; Nakagawa H; Horikiri T; Ueta M; Nakamura T; Inoue Y; Ohashi Y; Kinoshita S
    Br J Ophthalmol; 2017 Feb; 101(2):114-119. PubMed ID: 27142389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of adenoviral keratoconjunctivitis with a combination of povidone-iodine 1.0% and dexamethasone 0.1% drops: a clinical prospective controlled randomized study.
    Kovalyuk N; Kaiserman I; Mimouni M; Cohen O; Levartovsky S; Sherbany H; Mandelboim M
    Acta Ophthalmol; 2017 Dec; 95(8):e686-e692. PubMed ID: 28342227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dexamethasone/Povidone Eye Drops versus Artificial Tears for Treatment of Presumed Viral Conjunctivitis: A Randomized Clinical Trial.
    Pinto RD; Lira RP; Abe RY; Zacchia RS; Felix JP; Pereira AV; Arieta CE; de Castro RS; Bonon SH
    Curr Eye Res; 2015 Sep; 40(9):870-7. PubMed ID: 25310347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Treatment Models for Adenoviral Keratoconjunctivitis in the Childhood Population.
    Bekmez S; Eris E
    Ocul Immunol Inflamm; 2021 Nov; 29(7-8):1627-1632. PubMed ID: 32643975
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of topical cyclosporine a plus artificial tears versus artificial tears treatment on conjunctival goblet cell density in dysfunctional tear syndrome.
    Demiryay E; Yaylali V; Cetin EN; Yildirim C
    Eye Contact Lens; 2011 Sep; 37(5):312-5. PubMed ID: 21792057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-Term Topical Ganciclovir and Corticosteroids Preserve Corneal Endothelial Function in Cytomegalovirus Corneal Endotheliitis.
    Fan NW; Chung YC; Liu YC; Liu CJ; Kuo YS; Lin PY
    Cornea; 2016 May; 35(5):596-601. PubMed ID: 26967107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ganciclovir gel for cytomegalovirus keratouveitis.
    Pavan-Langston D; Welch CL; Zegans ME
    Ophthalmology; 2012 Nov; 119(11):2411. PubMed ID: 23122464
    [No Abstract]   [Full Text] [Related]  

  • 11. [Ocular pharmacokinetics and bioavailability of 0.2% ganciclovir in-situ gelling eye drops].
    Zhang JJ; Gao CF; Wang LY
    Zhonghua Yan Ke Za Zhi; 2006 Jul; 42(7):637-41. PubMed ID: 17081425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclosporin A eye drop and subepithelial adenoviral keratoconjunctivitis infiltrates.
    Zghal I; Fekih O; Zgolli HM; Chargui S; Malek I; Nacef L
    Tunis Med; 2019 May; 97(5):639-643. PubMed ID: 31729734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical assessment of oral ganciclovir capsules on the treatment of herpes simplex keratitis].
    Wang X; Xu JJ; LE QH; Wang Y; Wang WT
    Zhonghua Yan Ke Za Zhi; 2010 Nov; 46(11):994-9. PubMed ID: 21211295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and tolerability of a one-time, in-office administration of 5% povidone-iodine in the treatment of adenoviral conjunctivitis: The Reducing Adenoviral Patient Infected Days (RAPID) study.
    Shorter E; Whiteside M; Harthan J; Margolis MS; Hartwick AT; Johnson S; Migneco M; Morettin C; Olson CK; Huecker J; Than T; Gordon MO
    Ocul Surf; 2019 Oct; 17(4):828-832. PubMed ID: 31401340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of clinical outcome with different treatment regimens in acute adenoviral keratoconjunctivitis.
    Asena L; Şıngar Özdemir E; Burcu A; Ercan E; Çolak M; Altınörs DD
    Eye (Lond); 2017 May; 31(5):781-787. PubMed ID: 28157224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stability, safety, and pharmacokinetics of ganciclovir eye drops prepared from ganciclovir for intravenous infusion.
    Okumura N; Tanaka T; Fukui Y; Koizumi N
    Jpn J Ophthalmol; 2019 May; 63(3):289-296. PubMed ID: 30941593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intra-cameral level of ganciclovir gel, 0.15% following topical application for cytomegalovirus anterior segment infection: A pilot study.
    Waduthantri S; Zhou L; Chee SP
    PLoS One; 2018; 13(1):e0191850. PubMed ID: 29377953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topical Ganciclovir for Prophylaxis of Cytomegalovirus Endotheliitis in Endothelial Keratoplasty.
    Basilious A; Chew HF
    Cornea; 2019 Jan; 38(1):120-122. PubMed ID: 30379718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical evaluation of local ocular toxicity in candidate anti-adenoviral agents in vivo.
    Inoue H; Sonoda KH; Ishikawa M; Kadonosono K; Uchio E
    Ophthalmologica; 2009; 223(4):233-8. PubMed ID: 19262070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topical Tacrolimus for Corneal Subepithelial Infiltrates Secondary to Adenoviral Keratoconjunctivitis.
    Berisa Prado S; Riestra Ayora AC; Lisa Fernández C; Chacón Rodríguez M; Merayo-Lloves J; Alfonso Sánchez JF
    Cornea; 2017 Sep; 36(9):1102-1105. PubMed ID: 28704319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.